The breast cancer 1 and 2  early onset (BRCA1 and BRCA2) genes are important for double-strand break repair by homologous recombination Cells with inactivating mutations of the BRCA1 or BRCA2 tumor suppressor genes show increased sensitivity to Poly-ADP ribose polymerase (PARP)-inhibitors in vitro